Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2003 | 1 |
2004 | 3 |
2005 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
J Bone Miner Res. 2004 Aug;19(8):1241-9. doi: 10.1359/JBMR.040325. Epub 2004 Mar 29.
J Bone Miner Res. 2004.
PMID: 15231010
Free article.
Clinical Trial.
Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.
Recker R, Stakkestad JA, Chesnut CH 3rd, Christiansen C, Skag A, Hoiseth A, Ettinger M, Mahoney P, Schimmer RC, Delmas PD.
Recker R, et al. Among authors: skag a.
Bone. 2004 May;34(5):890-9. doi: 10.1016/j.bone.2004.01.008.
Bone. 2004.
PMID: 15121021
Clinical Trial.
Item in Clipboard
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.
Stakkestad JA, Benevolenskaya LI, Stepan JJ, Skag A, Nordby A, Oefjord E, Burdeska A, Jonkanski I, Mahoney P; Ibandronate Intravenous Study Group.
Stakkestad JA, et al. Among authors: skag a.
Ann Rheum Dis. 2003 Oct;62(10):969-75. doi: 10.1136/ard.62.10.969.
Ann Rheum Dis. 2003.
PMID: 12972476
Free PMC article.
Clinical Trial.
Item in Clipboard
Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
Ettinger MP, Felsenberg D, Harris ST, Wasnich R, Skag A, Hiltbrunner V, Wilson K, Schimmer RC, Miller PD.
Ettinger MP, et al. Among authors: skag a.
J Rheumatol. 2005 Oct;32(10):1968-74.
J Rheumatol. 2005.
PMID: 16206354
Clinical Trial.
Item in Clipboard
Risk factors for low bone mineral density among a large group of Norwegian women with fractures.
Omland LM, Tell GS, Ofjord S, Skag A.
Omland LM, et al. Among authors: skag a.
Eur J Epidemiol. 2000 Mar;16(3):223-9. doi: 10.1023/a:1007672331628.
Eur J Epidemiol. 2000.
PMID: 10870936
Item in Clipboard
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study.
Delmas PD, Recker RR, Chesnut CH 3rd, Skag A, Stakkestad JA, Emkey R, Gilbride J, Schimmer RC, Christiansen C.
Delmas PD, et al. Among authors: skag a.
Osteoporos Int. 2004 Oct;15(10):792-8. doi: 10.1007/s00198-004-1602-9. Epub 2004 Apr 8.
Osteoporos Int. 2004.
PMID: 15071723
Clinical Trial.
Item in Clipboard
Medicinal prevention of pre-diabetes--no purpose?
Øfjord ES, Skag A, Helberg S, Aarskog D, Risberg K, Jacobsen T, Nasrala S, Bakken S, Syversen U, Jenssen T.
Øfjord ES, et al. Among authors: skag a.
Tidsskr Nor Laegeforen. 2011 Aug 9;131(15):1418-9. doi: 10.4045/tidsskr.10.1459.
Tidsskr Nor Laegeforen. 2011.
PMID: 21844941
Free article.
English, Norwegian.
No abstract available.
Item in Clipboard
Cite
Cite